Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study
This study was aimed to evaluate serum KL-6 levels to determine if this marker can be used for diagnosing and assessing severity of interstitial lung disease (ILD) in children with connective tissue disorders. In total, 40 patients [18 patients with juvenile systemic lupus erythematosus (JSLE), 10 p...
Saved in:
Main Authors: | R. El-Beheidy (Author), A.M. Domouky (Author), H. Zidan (Author), Y.A. Amer (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interstitial lung disease in mixed connective tissue disease
by: Marshell Tendean, et al.
Published: (2017) -
Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
by: Valeria Nucera, et al.
Published: (2021) -
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021) -
KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case–Control Study
by: Chiu YH, et al.
Published: (2022) -
Selection of glucocorticoid-sensitive patients in interstitial lung disease secondary to connective tissue diseases population by radiomics
by: Feng DY, et al.
Published: (2018)